{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:24Z","timestamp":1787841324030,"version":"build-2784847793"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T00:00:00Z","timestamp":1452729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      We describe the association of familial multiple subcutaneous lipomatosis with a\n                      <jats:italic toggle=\"yes\">PALB2<\/jats:italic>\n                      gene mutation (c.2716delT) and its increased predilection to cancers.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.hemonc.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T18:33:58Z","timestamp":1453919638000},"page":"154-156","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["A rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased predilection to cancers"],"prefix":"10.4103","volume":"9","author":[{"given":"Neelesh","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baswantrao","family":"Malipatil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.hemonc.2016.01.001_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-7-23","article-title":"Review of Dercum\u2019s disease and proposal of diagnostic criteria, diagnostic methods, classification and management","volume":"7","author":"Hansson","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.hemonc.2016.01.001_b0010","first-page":"227","article-title":"Familial multiple lipomatosis: report of a new family","volume":"79","author":"Gologorsky","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.hemonc.2016.01.001_b0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/WNL.51.1.258","article-title":"Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA","volume":"51","author":"G\u00e1mez","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.hemonc.2016.01.001_b0020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","article-title":"Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2","volume":"22","author":"Xia","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.hemonc.2016.01.001_b0025","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","article-title":"Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations","volume":"7","author":"Fackenthal","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hemonc.2016.01.001_b0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene","volume":"39","author":"Rahman","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.hemonc.2016.01.001_b0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"Reid","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.hemonc.2016.01.001_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.228452.113","article-title":"Familial pancreatic cancer: genetic advances","volume":"28","author":"Rustgi","year":"2014","journal-title":"Genes Dev"},{"key":"10.1016\/j.hemonc.2016.01.001_b0045","doi-asserted-by":"crossref","first-page":"747318","DOI":"10.1155\/2013\/747318","article-title":"Hereditary breast cancer: the era of new susceptibility genes","volume":"2013","author":"Apostolou","year":"2013","journal-title":"Biomed Res Int"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387616000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658387616000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/02275670-201609040-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:48:59Z","timestamp":1787838539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02275670-201609040-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1016\/j.hemonc.2016.01.001","relation":{},"ISSN":["1658-3876"],"issn-type":[{"value":"1658-3876","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}